EFDID: 166216EFD: View Filing

Issuer: Ashvattha Therapeutics, LLC (0001668528) - D

Accession: 0000914760-16-000428 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001668528
  • Entity Name:
    Ashvattha Therapeutics, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    CALIFORNIA
  • Year of Inc:
    Within 5 years (2015)
  • Address:
    303 TWIN DOLPHIN DRIVE, SUITE 600
    REDWOOD CITY, CA 94065
  • Persons:
    Related Persons 4
    Jeffrey Cleland
    Executive Officer 
    Executive Chairman, President and Manager of Company
    Sujatha Kannan
    Executive Officer 
    Manager of Company
    Kannan Rangaramanujam
    Executive Officer 
    Manager of Company
    Justin Hanes
    Executive Officer 
    Manager of Company
EDGAR: Offering Information
  • Accession Date:
    06/07/2016
  • First Sale Date:
    05/23/2016
  • Offering Amount:
    $37,400
  • Amount Sold:
    $37,400
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    In connection with rights under a contractual arrangement.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA
Inactive:MD
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ashvattha Therapeutics, LLC/s/ Jeffrey ClelandJeffrey ClelandPresident2016-06-01